Skip to main content
Premium Trial:

Request an Annual Quote

Good News, and a Blast from the Past

Sure, it's probably been a long time since you've thought about Human Genome Sciences. But Venter's former business partner just announced positive results of its anthrax drug in animal studies, reports this article in the Wall Street Journal. The company said that "a single dose of its anthrax-fighting drug ABthrax -- without benefit of any additional antibiotics -- improved survival rates from inhalation of deadly anthrax spores by up to 64% in test subjects," according to the article.

 

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.